Traders Watch list: Liberty Latin America Ltd. (NASDAQ:LILA) & Second Sight Medical Products, Inc. (NASDAQ:EYES)

2

Liberty Latin America Ltd. (NASDAQ:LILA)

Liberty Latin America is a telecommunication company. Its business products and services include enterprise-grade connectivity, data center, hosting and managed solutions, as well as information technology solutions. It operates primarily in Chile, Puerto Rico, the Caribbean and other parts of Latin America. Liberty Latin America, formerly known as Liberty LiLAC, is based in DENVER.

Liberty Latin America Ltd. (NASDAQ:LILA)’s Financial Overview

Liberty Latin America Ltd. (NASDAQ) surged 1.26% yesterday to close its trading session at $18.5. The company has 1 year Price Target of $22.12. Liberty Latin America Ltd. has 52-Week high of $23.78 and 52-Week Low of $13.96. The stock touched its 52-Week High on 23.78 and 52-Week Low on 13.96. The stock traded with the volume of 551654 shares yesterday. The firm shows the market capitalization of $3.39 Billion.

Liberty Latin America Ltd. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.15/share against the analyst consensus estimate of $0.07/share. The difference between the actual and expected EPS is $-0.22 a share with a surprise factor of -314.3%.

The firm is trading with SMA20 of 9.26 Percent, SMA50 of 12.09 Percent and SMA200 of -2.65 percent. Liberty Latin America Ltd. has P/S value of 0.94 while its P/B value stands at 1.01. Similarly, the company has Return on Assets of -3.7 percent, Return on Equity of -15.9 percent and Return on Investment of -4.4 Percent. The company shows Gross Margin and Operating Margin of 75.9 percent and 3 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 12 analysts offering 12-month price forecasts for Liberty Latin America Ltd have a median target of 21.50, with a high estimate of 29.00 and a low estimate of 19.00. The median estimate represents a +16.22% increase from the last price of 18.50.

Liberty Latin America Ltd. is estimated to report earnings on 02/13/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.42.

Second Sight Medical Products, Inc. (NASDAQ:EYES)

Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California.

Second Sight Medical Products, Inc. (NASDAQ:EYES)’s Financial Outlook

The 1 analysts offering 12-month price forecasts for Second Sight Medical Products Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +590.13% increase from the last price of 0.72.

Second Sight Medical Products, Inc. is estimated to report earnings on 03/06/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.11. The reported EPS for the same quarter last year was $-0.16.

According to Zacks Investment Research, Second Sight Medical Products, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged 5.77% and closed its last trading session at $0.72. The company has the market capitalization of $56.94 Million. The stock has 52-week high of $2.25 and 52-Week low of $0.635. The firm touched its 52-Week high on 2.25 and 52-Week low on 0.64. The company has volume of 819275 shares. The company has a total of 78.59 Million shares outstanding.

Second Sight Medical Products, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.12/share where the analyst estimated EPS was $-0.14/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 14.3 percent.

The company has YTD performance of -18.18 percent. Beta for Second Sight Medical Products, Inc. stands at 2.26 while its ATR (average true range) is 0.05. The company has Weekly Volatility of 6.92%% and Monthly Volatility of 6.33%%.

Second Sight Medical Products, Inc. has distance from 20-day Simple Moving Average (SMA20) of -9.05%, Distance from 50-Day Simple Moving Average of -18.03 percent and Distance from 200-Day Simple Moving Average of -51.41%.

The Company currently has ROA (Return on Assets) of -269.5 percent, Return on Equity (ROE) of -616 Percent and Return on Investment (ROI) of -362.1% with Gross margin of 37.5 percent and Operating & Profit margin of 0% and 0% respectively.

SHARE